U.S. markets closed

Hikma Pharmaceuticals PLC (HKMPF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
35.33+0.08 (+0.23%)
At close: 1:03PM EST
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Annual
Quarterly
Premium required to access monthly data
Monthly
Subscribe to Premium to download historical data
 
As of Date: 11/21/2020
Current
Market Cap (intraday) 5
8.08B
Enterprise Value 3
8.57B
Trailing P/E
16.55
Forward P/E 1
19.01
PEG Ratio (5 yr expected) 1
2.59
Price/Sales (ttm)
3.70
Price/Book (mrq)
4.26
Enterprise Value/Revenue 3
3.74
Enterprise Value/EBITDA 6
13.15

Trading Information

Stock Price History

Beta (5Y Monthly) 0.01
52-Week Change 341.85%
S&P500 52-Week Change 315.28%
52 Week High 342.00
52 Week Low 319.75
50-Day Moving Average 334.23
200-Day Moving Average 331.23

Share Statistics

Avg Vol (3 month) 31.14k
Avg Vol (10 day) 33.27k
Shares Outstanding 5230.5M
Float 173.93M
% Held by Insiders 128.57%
% Held by Institutions 140.12%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 40.31
Forward Annual Dividend Yield 40.90%
Trailing Annual Dividend Rate 30.46
Trailing Annual Dividend Yield 31.30%
5 Year Average Dividend Yield 41.57
Payout Ratio 422.27%
Dividend Date 3May 25, 2011
Ex-Dividend Date 4Aug 19, 2020
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Jun 29, 2020

Profitability

Profit Margin 22.38%
Operating Margin (ttm)22.25%

Management Effectiveness

Return on Assets (ttm)8.42%
Return on Equity (ttm)27.46%

Income Statement

Revenue (ttm)2.29B
Revenue Per Share (ttm)9.47
Quarterly Revenue Growth (yoy)8.10%
Gross Profit (ttm)1.09B
EBITDA 614M
Net Income Avi to Common (ttm)513M
Diluted EPS (ttm)2.11
Quarterly Earnings Growth (yoy)14.60%

Balance Sheet

Total Cash (mrq)436M
Total Cash Per Share (mrq)1.79
Total Debt (mrq)927M
Total Debt/Equity (mrq)48.79
Current Ratio (mrq)1.75
Book Value Per Share (mrq)7.77

Cash Flow Statement

Operating Cash Flow (ttm)572M
Levered Free Cash Flow (ttm)349M